Pfizer Inc
Pfizer's GHG Emissions Data Preview
In 2024, Pfizer completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).
Pfizer has also provided a category-level breakdown for 10 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Market-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Location-Based | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
Insights into Pfizer's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Pfizer amounted to 1,063,311 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Pfizer decreased by 1.41%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
Pfizer's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Pfizer's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Pfizer were 613,218 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Has Pfizer reduced its Scope 1 emissions over time?
Since 2018, Pfizer's Scope 1 emissions have decreased by 18.99%, reflecting a declining long-term trend in Scope 1 emissions over time.
Compared to the previous year (2023), Pfizer's Scope 1 emissions remained relatively stable, indicating that Pfizer's emissions have plateaued with no significant change in its operational footprint.
What are Pfizer's Scope 2 emissions?
In 2024, Pfizer reported Scope 2 greenhouse gas (GHG) emissions of 465,128 tCOâ‚‚e using the market-based method, and 450,093 tCOâ‚‚e using the location-based method.
Has Pfizer reduced its Scope 2 emissions over time?
Since 2018, Pfizer's Scope 2 greenhouse gas (GHG) emissions (Location-Based) have decreased by 51.07%, reflecting a declining long-term trend in Scope 2 emissions over time.
Compared to the previous year (2023), Pfizer's Scope 2 emissions (Location-Based) have remained relatively stable, indicating that Pfizer 's emissions have plateaued with no significant change in its energy consumption footprint.
What methodology does Pfizer use for Scope 2 reporting?
In 2024, Pfizer reported its Scope 2 emissions using the market-based method and using the location-based method.
Pfizer's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
- Total Scope 2 Market-Based
Insights into Pfizer's Value Chain Emissions
In 2024, Pfizer reported 3,555,207 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.
The 2024 disclosure of Pfizer includes a breakdown across 8 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.
Pfizer's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Pfizer's Scope 3 emissions?
In 2024, Pfizer reported total Scope 3 emissions of 3,555,207 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Approximately 99.77% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0.23% came from downstream activities like product use, distribution, and end-of-life treatment.
Has Pfizer reduced its Scope 3 emissions over time?
Since 2018, Pfizer's Scope 3 emissions have remained relatively stable, indicating that Pfizer 's emissions have plateaued with no significant change in its value chain footprint.
Compared to the previous year (2023), Pfizer's Scope 3 emissions decreased by 17.39%, highlighting the company's efforts to lower indirect emissions from its value chain.
What categories of Scope 3 emissions does Pfizer disclose?
In 2024, Pfizer reported emissions for 8 out of the 15 Scope 3 categories defined by the GHG Protocol.
This partial disclosure allows for some insight into the company's indirect impacts.
What are the main sources of Pfizer's Scope 3 emissions?
In 2024, the largest contributors to Pfizer's Scope 3 emissions were:
- Purchased Goods and Services (Cat. 1): 2,786,489 tCOâ‚‚e (86.73%)
- Fuel- and Energy-Related Services (Cat. 3): 254,803 tCOâ‚‚e (7.93%)
- Capital Goods (Cat. 2): 119,357 tCOâ‚‚e (3.71%)
Pfizer's Scope 3 Emissions by Categories
Insights into Pfizer's Total Carbon Footprint
In 2024, Pfizer reported a total carbon footprint of 4,618,518 metric tons of COâ‚‚ equivalent (tCOâ‚‚e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 14.19% decrease compared to 2023, indicating progress in reducing its overall greenhouse gas output.
The largest contributor to Pfizer's total carbon footprint was Scope 3 emissions, accounting for 76.98% of the company's total carbon footprint, followed by Scope 1 emissions at 13.28%.